ARRAY BIOPHARMA INC's ticker is and the CUSIP is 04269XAA3. A total of 14 filers reported holding ARRAY BIOPHARMA INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $18,385,000 | +33.2% | 13,500,000 | +39.4% | 0.04% | +34.6% |
| Q1 2017 | $13,798,000 | +145.9% | 9,683,000 | +142.1% | 0.03% | +136.4% |
| Q4 2016 | $5,612,000 | +172.7% | 4,000,000 | +100.0% | 0.01% | +120.0% |
| Q1 2014 | $2,058,000 | -76.7% | 2,000,000 | -76.5% | 0.01% | -75.0% |
| Q4 2013 | $8,829,000 | -3.9% | 8,500,000 | +6.2% | 0.02% | -9.1% |
| Q3 2013 | $9,185,000 | +93.0% | 8,000,000 | +60.0% | 0.02% | +100.0% |
| Q2 2013 | $4,759,000 | – | 5,000,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 45,000,000 | $53,278,000 | 2.48% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 5,000,000 | $6,018,000 | 0.85% |
| CSS LLC/IL | 10,546,000 | $12,816,000 | 0.62% |
| Verition Fund Management LLC | 3,400,000 | $4,025,000 | 0.43% |
| Redmile Group, LLC | 4,000,000 | $4,761,000 | 0.38% |
| OAKTREE CAPITAL MANAGEMENT LP | 19,600,000 | $23,231,000 | 0.30% |
| WOLVERINE ASSET MANAGEMENT LLC | 11,139,000 | $13,378,000 | 0.20% |
| LINDEN ADVISORS LP | 2,000,000 | $2,374,000 | 0.11% |
| Fernwood Investment Management, LLC | 90,000 | $106,000 | 0.10% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 5,000,000 | $5,909,000,000 | 0.09% |